Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
32.68
-0.41 (-1.24%)
May 18, 2026, 9:48 AM EDT - Market open
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $3.52 billion as of May 18, 2026. Its market cap has increased by 100.49% in one year.
Market Cap
3.52B
Enterprise Value
3.06B
1-Year Change
100.49%
Ranking
Category
Stock Price
$32.68
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $3.52B, an increase of 362.00%. That is a compound annual growth rate of 34.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 3.56B | 35.52% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caris Life Sciences | 4.11B |
| Veradermics | 4.11B |
| NewAmsterdam Pharma Company | 4.07B |
| Travere Therapeutics | 3.96B |
| Crinetics Pharmaceuticals | 3.88B |
| Catalyst Pharmaceuticals | 3.82B |
| Oruka Therapeutics | 3.74B |
| ACADIA Pharmaceuticals | 3.66B |